Findings from a new Cleveland Clinic-led study show that intensifying hypertensive treatment in an inpatient setting may do more harm than good.
The technology is available to empower patients to monitor their blood pressure at home. The main limiting factor is how well monitoring devices are integrated into your practice and workflow.
We’re using our ambulatory blood pressure monitoring program to assess the prevalence of masked hypertension in cardiac rehab patients and potentially improve hypertension control in people with aortic dissection.
Cleveland Clinic’s Department of Nephrology and Hypertension, within the Glickman Urological and Kidney Institute, receives prestigious designation from the American Heart Association.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Here’s a primer on how to ensure the most accurate blood pressure readings, from two noted nephrologists.
A clinical hypertension specialist identifies the 2017 ACC/AHA guideline’s five key contributions and shares tips on combination therapy, the role of home blood pressure monitoring and more.
Progress in kidney transplantation has improved survival, and created challenges. The pool of eligible patients is increasing, but organ supply still remains inadequate. Here are some of the issues.
The new ACC/AHA recommendations are a helpful development, but Cleveland Clinic experts say they miss the boat on patients with diabetes and the need to individualize treatment.
Why does kidney disease disproportionately affect minorities? What is the connection between renal disease, diabetes and hypertension? These are some of the issues Cleveland Clinic renal disease researchers are pursuing.
Instead of one in three U.S. adults having hypertension, nearly one in two will now be classified as having hypertension. Accurate measurements in and out of the office are key. Lifestyle changes are getting major emphasis.